Amyris Inc
(STU:3A01)
€
0.055
0 (0%)
Market Cap: 692,000.00
Enterprise Value: -
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 Amyris Inc at UBS Global Healthcare Conference Transcript
May 25, 2022 / 03:30PM GMT
Release Date Price:
€2.01
(-5.50%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
I'm John Sourbeer. I cover life sciences diagnostic tools and pharma services for UBS. Posting our next fireside chat here with Amyris, and we have John Melo, President and CEO, with us today. Hi, John.
John G. Melo
Amyris, Inc. - President, CEO & Director
Hi, John. How are you?
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Doing great.
Questions & Answers
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
So I guess, maybe just to kind of start off high level to kick things off here, maybe some that are new to the Amyris story. Could you just kind of run through where the company is today and how you're positioned?
John G. Melo
Amyris, Inc. - President, CEO & Director
Sure, John. Happy to do that. First of all, great to be here. Great to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot